Mass General Brigham Ventures
Corporate VCBoston · Seed–Series A · 5 people tracked
Investment thesis
Through its Artificial Intelligence and Digital Innovation Fund, Mass General Brigham Ventures backs venture-stage companies whose products and services advance the health system's strategic priorities, with a focus on artificial intelligence and digital innovation in healthcare.
Source: firm website, verified Aug 11, 2026.
Team · 5 people
from curated
What they invest in
from 3 of 3 portfolio companiesBiotech ×2Healthtech ×2AI & Machine Learning ×1Digital Health ×1
HQs:United States×3
Investments · 3 tracked
founders shown can be your intro pathBy year:2025 · 12020 · 12 dated
Abcuro develops therapies that target highly cytotoxic T cells for autoimmune diseases, including its lead candidate ulviprubart for inclusion body myositis.
BiotechHealthtechNewton, US
Steven A. Greenberg(Chief Scientific Advisor & Co-Founder)Steven A. Greenberg, MD(Chief Scientific Advisor & Co-Founder)John Alexander Martin(Executive Officer, Director)Stefano Gulla(Executive Officer)Evan Thompson(Executive Officer)David de Graaf(Executive Officer, Director)
Co-investorsBain Capital Life SciencesNew Enterprise Associates (NEA)RA CapitalSamsara BioCapitalSanofi VenturesREDMILE+8 more
BiotechBoston, US
BoardScott Rocklage(Executive Officer, Director)David Allison(Director)
Board seatMeredith FisherRoger Kitterman· per SEC Form D · $20M raise · filed Aug 2020
CodaMetrix operates an AI-based contextual coding automation platform that converts clinical data and chargeable activities into billable, clinical, and demographic medical codes for hospitals and health systems.
AI & Machine LearningDigital HealthHealthtechBoston, US
Hamid Tabatabaie(Director, Executive Officer, Promoter)Mark Pottle(Executive Officer)Jim Whelan(Mr. Whelan is the Chief Revenue Officer of the Issuer.)Kevin Schmitt(Mr. Schmitt is the Chief Engineering Officer of the Issuer.)Jay Aslam(Mr. Aslam is the Chief Data Science Officer of the Issuer.)Tara Bradley(Executive Officer)
Board seatRoger Kitterman· per SEC Form D · $15M raise · filed May 2025
Co-investorsCU Healthcare Innovation FundFrist Cressey VenturesMartin VenturesSignalFireTRANSFORMATION CAPITAL
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Portfolio news
latest coverage across their companies
Abcuro · clinicaltrialsarena.com · Aug 19, 2026
Frequently asked questions
- What stage does Mass General Brigham Ventures invest at?
- Mass General Brigham Ventures invests at the Seed, Series A stages.
- What sectors does Mass General Brigham Ventures focus on?
- Mass General Brigham Ventures focuses on AI & Machine Learning, Biotech, Digital Health, Healthtech, Medical Devices.
- Where is Mass General Brigham Ventures located?
- Mass General Brigham Ventures is headquartered in Boston, US.
Similar investors
Eight Roads Ventures is a venture capital firm that backs and partners with technology and healthcare companies.
Kleiner Perkins is a venture capital firm that backs founders across technology and life sciences, from early stage through growth.
Averin Capital is an investment firm focused on the intersection of technology and health, backing teams building companies in areas such as early disease detection, treatment delivery, personalized care, and medical breakthroughs.
Medical Excellence Capital (MEC) is a venture firm focused on precision health and life sciences, pairing investment professionals and operators with a proprietary national medical network platform.
MedMountain Ventures (MMV) is an early-stage healthcare investment firm founded by board-certified physicians and seasoned healthcare operators, backing companies that improve patient outcomes and reshape how care is delivered, financed, and accessed.